This session offers a detailed exploration of mitral TEER intraprocedural guidance through case-based learning. It highlights step-by-step techniques, including post-processing and key questions interventionalists face regarding residual regurgitation, clip insertion, and evaluating final procedural outcomes.

This session offers a detailed evaluation framework for the tricuspid valve, encompassing clinical decision-making, anatomical assessment with 2D and 3D imaging, quantification of regurgitation, and differentiation of secondary and device-related tricuspid regurgitation, supported by advanced imaging software techniques.

Discover the minimalist approach to tricuspid valve therapy showcased through TricValve implantation, emphasizing a contrast-free, minimally invasive procedure guided by transthoracic echo and minimal fluoroscopy. Review clinical evidence demonstrating reduced hospitalizations, improved quality of life, and favorable mid-term outcomes such as decreased right heart chamber dimensions...

Delve into the complexities of TAVI outcomes in special clinical populations including patients with cancer, diabetes, and frailty. This session reviews critical analyses and meta-analyses addressing ischemic cerebrovascular events post-TAVI, and compares mortality and post-procedural outcomes between diabetic and non-diabetic patients, providing valuable insights for personalized...

Complications

Perforations can be life threating complications, but if recognised quickly and managed correctly can have a positive outcome. This section explains how to treat a coronary perforation.
In total there are 5 types.

PCR Complication Team: Patrick Calvert, Eric Eeckhout, Michael Haude, Amir Lerman, Olivier Muller

There are five types...

How would you treat this 62-year-old female patient with NYHA class III/IV symptoms, degeneration of mitral valve repair (with annuloplasty ring - 2008) with significant MR, and high surgical risk?

View the case of a 60-year-old male patient who was diagnosed with pulmonary embolism and a large TIT, and see how he was treated by percutaneous thrombectomy.

Watch the case of a 79-year-old male patient admitted to hospital with progressive dyspnea in NYHA functional class III-IV and signs of fluid overload, who presented a subannular perforation of LVOT in the region of fibrous aortomitral continuity, and find out how he was treated.

The authors present a case of percutaneous coronary intervention for bifurcation lesion in a 73-year-old man suffering from effort angina, in which they successfully performed double kissing crush stenting using optical coherence tomography.

Over the last 30 years, primary PCI (pPCI) has evolved from an experimental ‘rescue’ intervention to an essential routine procedure – performed daily in cathlabs around the world – which is responsible for saving millions of lives. However, its path to success was far from smooth.

Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.

It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...

Because of the current COVID-19 environment with an exponential development of ‘digital format of postgraduate learning events’, often on the same topics, it seems essential to remember the foundation of effective post graduate learning in the field of medicine, and how we...

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.

Claudio Laudani and Daniele Giacoppo report the main results of the ILUMIEN IV trial presented by Ziad Ali, from the St. Francis Hospital, Roslyn, and Clinical Trials Center, Cardiovascular Research Foundation, New York, in a Hot Line session at the European Society of Cardiology congress 2023...